Pre-Session Views
Episode 7 min 34s

Pre-Session Views

In today's Pre-Session Views: Strategy| PHDC investors have already shaved off the fees imposed by NUCA from MCAP. Time to rebuild long positionsEFID| EFID exclusion from EGX30 supports short EFID callTMGH| SouthMed shouldn’t be exposed to NUCA fee riskETEL| 2Q25 expectations – no surprisesDSCW| (BUY- FV: EGP5.5/share) 2Q25 recovery led by volumes; margins improve q/q but remain under pressure, foreign entrants viewed as strategic upsideMCQE| EGX30 inclusion adds fuel to fire as stock crawls ...

Community discussion